Zentalis Pharmaceuticals, Inc. (ZNTL) Financials
ZNTL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 562.0 million | 124.6 million |
2023-09-30 | 585.7 million | 103.8 million |
2023-06-30 | 621.4 million | 98.2 million |
2023-03-31 | 489.3 million | 103.7 million |
ZNTL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -40.8 million | 13.9 million |
2023-09-30 | -38.8 million | 13.9 million |
2023-06-30 | -79.6 million | 13.3 million |
2023-03-31 | -49.3 million | 13.7 million |
ZNTL Net Income
No data available :(
ZNTL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 482.9 million | - | 43.2 million |
2023-09-30 | 516.6 million | - | 45.7 million |
2023-06-30 | 553.0 million | - | 46.4 million |
2023-03-31 | 392.5 million | - | 44.8 million |
ZNTL Shares Outstanding
ZNTL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 173000 | 51.6 million | 16.4 million | 337001 |
2023-09-30 | 91000 | 46.8 million | 16.0 million | - |
2023-06-30 | 319000 | 42.7 million | 15.7 million | - |
2023-03-31 | 209000 | 48.6 million | 16.4 million | - |
ZNTL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 337000 |
2023-09-30 | - | 348000 |
2023-06-30 | - | 344000 |
2023-03-31 | - | 360000 |
ZNTL
Price: $11.71
52 week price:
Earnings Per Share: -4.47 USD
P/E Ratio: -2.52
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 349136
Market Capitalization: 831.6 million